173 related articles for article (PubMed ID: 37581107)
1. Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease.
Yang C; Yang L; Yang L; Li S; Ye L; Ye J; Chen C; Zeng Y; Zhu M; Lin X; Peng Q; Wang Y; Jin M
Int J Chron Obstruct Pulmon Dis; 2023; 18():1713-1728. PubMed ID: 37581107
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of Serum Proteins in Chronic Obstructive Pulmonary Disease Assessed Using Label-Free Proteomics and Bioinformatics Analyses.
Li R; Zhao X; Liu P; Wang D; Chen C; Wang Y; Zhang N; Shen B; Zhao D
Int J Chron Obstruct Pulmon Dis; 2022; 17():2871-2891. PubMed ID: 36411774
[TBL] [Abstract][Full Text] [Related]
3. Serum Proteomic Profiling in Patients with Chronic Obstructive Pulmonary Disease.
Wu S; Huang K; Chang C; Chu X; Zhang K; Li B; Yang T
Int J Chron Obstruct Pulmon Dis; 2023; 18():1623-1635. PubMed ID: 37533772
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
[TBL] [Abstract][Full Text] [Related]
5. Application Value of Blood Heparin-Binding Protein in the Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Dong Y; Zhou X; Zhang Y; Liu Y; Zhou X; Ren G; Li Q
Contrast Media Mol Imaging; 2021; 2021():3800211. PubMed ID: 35024012
[TBL] [Abstract][Full Text] [Related]
6. Identification of thyroxine-binding globulin as a candidate plasma marker of chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Sun X; Liu B; Xu M; He B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1549-1564. PubMed ID: 28579773
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype.
Ding HZ; Wang H; Wu D; Zhou FC; Zhu J; Tong JB; Gao YT; Li ZG
Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38873983
[TBL] [Abstract][Full Text] [Related]
8. Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease.
Das S; Adiody S; Varghese J; Vanditha M; Maria E; John M
Clin Proteomics; 2024 Feb; 21(1):10. PubMed ID: 38355435
[TBL] [Abstract][Full Text] [Related]
9. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
Su L; Qiao Y; Luo J; Huang R; Xiao Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
[TBL] [Abstract][Full Text] [Related]
10. Serum BLMH and CKM as Potential Biomarkers for Predicting Therapeutic Effects of Deep Brain Stimulation in Parkinson's Disease: A Proteomics Study.
Gong Y; Qian S; Chen D; Ye M; Wu J; Wang YL
J Integr Neurosci; 2023 Nov; 22(6):163. PubMed ID: 38176938
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of uric acid and uric acid-to-creatinine ratio as a predictive factor of chronic obstructive pulmonary disease exacerbation in 2019.
Barmehziar S; Fadaii A; Samadian F; Shakiba A; Koolaji S
Clin Respir J; 2023 Oct; 17(10):1025-1037. PubMed ID: 37643874
[TBL] [Abstract][Full Text] [Related]
12. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
Geerdink JX; Simons SO; Pike R; Stauss HJ; Heijdra YF; Hurst JR
Respir Res; 2016 Oct; 17(1):140. PubMed ID: 27793198
[TBL] [Abstract][Full Text] [Related]
13. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD.
Wei X; Ma Z; Yu N; Ren J; Jin C; Mi J; Shi M; Tian L; Gao Y; Guo Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():121-129. PubMed ID: 29343951
[TBL] [Abstract][Full Text] [Related]
14. Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations.
Scioscia G; Blanco I; Arismendi E; Burgos F; Gistau C; Foschino Barbaro MP; Celli B; O'Donnell DE; Agustí A
Thorax; 2017 Feb; 72(2):117-121. PubMed ID: 27586869
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
[TBL] [Abstract][Full Text] [Related]
16. A Proteomics-Based Analysis of Blood Biomarkers for the Diagnosis of COPD Acute Exacerbation.
Kim SH; Ahn HS; Park JS; Yeom J; Yu J; Kim K; Oh YM
Int J Chron Obstruct Pulmon Dis; 2021; 16():1497-1508. PubMed ID: 34113087
[TBL] [Abstract][Full Text] [Related]
17. Identification of proteomic signatures associated with COPD frequent exacerbators.
Sun P; Ye R; Wang C; Bai S; Zhao L
Life Sci; 2019 Aug; 230():1-9. PubMed ID: 31121174
[TBL] [Abstract][Full Text] [Related]
18. A2M Serves as Promising Biomarker for Chronic Obstructive Pulmonary Disease.
Xiao X; Cai W; Ding Z; Shi Y; Fan L; Zhang Q
Int J Chron Obstruct Pulmon Dis; 2023; 18():683-692. PubMed ID: 37123074
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma osteopontin in frequent exacerbator and acute exacerbation of COPD.
Lee SJ; Kim SH; Kim W; Lim S; Lee SH; Kim YE; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS
Clin Respir J; 2014 Jul; 8(3):305-11. PubMed ID: 24188595
[TBL] [Abstract][Full Text] [Related]
20. No association between exacerbation frequency and stroke in patients with COPD.
Windsor C; Herrett E; Smeeth L; Quint JK
Int J Chron Obstruct Pulmon Dis; 2016; 11():217-25. PubMed ID: 26893553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
